BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04198766-completion@plaintrial.com
DTSTAMP:20261028T024159Z
DTSTART;VALUE=DATE:20270512
SUMMARY:Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab 
 (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors 
 (Hexavalent OX40 Agonist) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04198766
URL:https://plaintrial.com/trial/NCT04198766
END:VEVENT
END:VCALENDAR